Calculation of the pharmacogenomics benefit score for patients with medication-related problems

Calculation of the pharmacogenomics benefit score for patients with medication-related problems

Unexpected poor efficacy and intolerable adverse effects are medication-related problems that may result from genetic variation in genes encoding key proteins involved in pharmacokinetics or pharmacodynamics. Pharmacogenomic (PGx) testing can be used in medical practice “pre-emptively” to avoid futu...

Full description

Bibliographic Details
Main Author:	Thomas M. Polasek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Genetics
Subjects:	pharmacogenomics benefit score pharmacogenomics precision medicine precision dosing adverse drug reactions
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1152585/full

Similar Items

Virtual twin for healthcare management
by: Thomas M. Polasek, et al.
Published: (2023-09-01)

Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics
by: Kevin T. Bain, et al.
Published: (2020-02-01)

Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
by: Cathelijne H. van der Wouden, et al.
Published: (2022-06-01)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
by: Aurélien Simona, et al.
Published: (2023-06-01)

Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
by: Zeina N. Al-Mahayri, et al.
Published: (2022-09-01)

Web Resources for Pharmacogenomics
by: Guoqing Zhang, et al.
Published: (2015-02-01)

Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
by: Debleena Guin, et al.
Published: (2019-08-01)

A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy
by: Antonella Riva, et al.
Published: (2023-09-01)

Pharmacogenomics and health disparities, are we helping?
by: Sherin Shaaban, et al.
Published: (2023-01-01)

Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
by: Debleena Guin, et al.
Published: (2020-12-01)

Pharmacogenomics in drug discovery and development /
by: Yan, Qing, 1971-
Published: (2008)

An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
by: Aimeé Salas-Hernández, et al.
Published: (2023-05-01)

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
by: Shuqin Zhou, et al.
Published: (2018-12-01)

Population Pharmacogenomics for Precision Public Health in Colombia
by: Shashwat Deepali Nagar, et al.
Published: (2019-03-01)

Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis
by: Saibal Das, et al.
Published: (2024-10-01)

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
by: Patricia Esperón, et al.
Published: (2022-01-01)

Pharmacogenomics in the newborn
by: Mirta Corsello, et al.
Published: (2013-08-01)

Complexities of pharmacogenomic interactions in cancer
by: Kum Kum Khanna, et al.
Published: (2020-05-01)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
by: Qihui Shao, et al.
Published: (2021-09-01)

Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
by: Aliya A. Rizvi, et al.
Published: (2022-06-01)

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
by: Habiba Abdelhalim, et al.
Published: (2022-07-01)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
by: Anthi Maslarinou, et al.
Published: (2023-05-01)

Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma
by: Xing Zhou, et al.
Published: (2025-02-01)

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease
by: Theodora Katsila, et al.
Published: (2016-03-01)

Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives
by: Kholoud Bastaki, et al.
Published: (2024-03-01)

Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
by: Borbón A, et al.
Published: (2025-01-01)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
by: Shivashankar H. Nagaraj, et al.
Published: (2021-09-01)

Pharmacogenomics and Rheumatological Practice
by: Chuanhui Xu, et al.
Published: (2021-12-01)

Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)

Pharmacogenomics at the post-pandemic: If not now, then when?
by: Zeina N. Al-Mahayri
Published: (2022-09-01)

Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine
by: Lejla Mahmutovic, et al.
Published: (2018-11-01)

Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024-02-01)

Advancing Precision Medicine in Paediatrics: Past, present and future
by: Abdelbaset Elzagallaai, et al.
Published: (2023-01-01)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
by: Kanyawan Tiwattanon, et al.
Published: (2022-07-01)

A Case for Pharmacogenomics in Management of Cardiac Arrhythmias
by: Gaurav Kandoi, et al.
Published: (2012-03-01)

Pharmacogenomics /
by: Kalow, Werner, et al.
Published: (2005)

Are we PREPAREd? Concerning the “PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study”
by: Ana de Carmo Campos, et al.
Published: (2023-10-01)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
by: Masahiro Hiratsuka, et al.
Published: (2021-08-01)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
by: Roman YM
Published: (2021-03-01)

Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01)